Aliaxin SR Cross-Linked Hyaluronic Acid
Philippines·Rose Pharma S.A. Via San Gottardo 10-6900 Lugano, Switzerland·Switserland·Issued January 23, 2025 – January 25, 2030- Product Name
- Aliaxin SR Cross-Linked Hyaluronic Acid
- Registration Number
- CMDR-2025-03700
- Country of Origin
- Switserland
- Importer/Distributor
- Metro Drug, Inc.
- Issuance Date
- January 23, 2025
- Expiry Date
- January 25, 2030
Access comprehensive regulatory information for Aliaxin SR Cross-Linked Hyaluronic Acid in the Philippines medical device market through Pure Global AI's free database. This device is registered under FDA registration number CMDR-2025-03700 and manufactured by Rose Pharma S.A. Via San Gottardo 10-6900 Lugano, Switzerland in Switserland. The device was registered on January 23, 2025.
This page provides complete registration details including manufacturer information, importer/distributor details (Metro Drug, Inc.), and regulatory compliance data from the official Philippines FDA medical device database. Pure Global AI offers free access to Philippines' complete medical device registry, helping global MedTech companies navigate FDA regulations efficiently.